66774-70-7

Basic information

• Product Name: Benzoic acid 1-(2-hydroxy-1-methyl-ethyl)-7a-methyl-octahydro-inden-4-yl ester
• Synonyms: Benzoic acid 1-(2-hydroxy-1-methyl-ethyl)-7a-methyl-octahydro-inden-4-yl ester;Benzoic acid 1S-(2-hydroxy-1R-methyl-ethyl)-7R-methyl-octahydro-inden-4R-yl ester
• CAS NO: 66774-70-7
• Molecular Formula: C₂₀H₂₈O₃
• Molecular Weight: 316.43
• Mol File: 66774-70-7.mol
• Article Data: 16

Chemical Properties

• Boiling Point: 427.324°C at 760 mmHg
• Flash Point: 167.923°C
• Appearance: /
• Density: 1.11g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.55
• CAS DataBase Reference: Benzoic acid 1-(2-hydroxy-1-methyl-ethyl)-7a-methyl-octahydro-inden-4-yl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid 1-(2-hydroxy-1-methyl-ethyl)-7a-methyl-octahydro-inden-4-yl ester(66774-70-7)
• EPA Substance Registry System: Benzoic acid 1-(2-hydroxy-1-methyl-ethyl)-7a-methyl-octahydro-inden-4-yl ester(66774-70-7)

Safety Data

• Hazardous Substances Data: 66774-70-7(Hazardous Substances Data)

Usage

InChI:InChI=1/C20H28O3/c1-14(13-21)16-10-11-17-18(9-6-12-20(16,17)2)23-19(22)15-7-4-3-5-8-15/h3-5,7-8,14,16-18,21H,6,9-13H2,1-2H3/t14-,16-,17?,18+,20-/m1/s1

Upstream product

• 98-88-4 benzoyl chloride 
• 66774-71-8 Benzoic acid (1R,3aR,4S,7aR)-7a-methyl-1-((S)-1-methyl-2-oxo-ethyl)-octahydro-inden-4-yl ester 
• 115527-12-3 (20R)-des-A,B-8β-(benzoyloxy)-23,24-dinorcholan-22-al 
• 64190-52-9 (8S,20S)-de-A,B-20-(hydroxymethyl)pregnan-8-ol 
• 55812-82-3 (1R,3aR,4S,7aR)-7a-methyl-1-<(2E)-(1R,4R)-1,4,5-trimethyl-hex-2-enyl>-octahydro-1H-inden-4-ol 
• 68702-86-3 (24R,22E)-des-A,B-8β-(benzoyloxy)ergost-22-ene 
• 50-14-6 Calciferol 

Downstream Products

• 66774-71-8 Benzoic acid (1R,3aR,4S,7aR)-7a-methyl-1-((S)-1-methyl-2-oxo-ethyl)-octahydro-inden-4-yl ester 
• 138079-57-9 Benzoic acid (1R,3aR,4S,7aR)-1-((E)-(1R,4S)-5-hydroxy-1,4,5-trimethyl-hex-2-enyl)-7a-methyl-octahydro-inden-4-yl ester 
• 100858-26-2 (22E,24S)-de-A,B-25-<(methoxymethyl)oxy>ergost-22-en-8-one 
• 100858-24-0 (22E,24S)-de-A,B-8β-(benzoyloxy)-25-<(methoxymethyl)oxy>ergost-22-ene 
• 98830-20-7 25-hydroxydihydrotachysterol₂ 
• 1016256-91-9 (8S,20R)-des-A,B-8-benzoyloxy-20-[(4'S)-(tertbutyldimethylsilyl)oxy-pent-(1'E)-en-yl]-pregnane 
• 1016232-58-8 (8S,20S)-des-A,B-8-benzoyloxy-20-[(4'S)-(tertbutyldimethylsilyl)oxy-pent-(1'E)-en-yl]-pregnane 
• 1283571-18-5 (8S,20S)-des-A,B-8-benzoyloxy-20-[4'-(tertbutyldimethylsilyloxy)-4'-methyl-pent-(1'E)-en-yl]-pregnane 
• 1283571-16-3 (8S,20S)-des-A,B-8-benzoyloxy-20-[4'-hydroxy-4'-methylpent-(1'E)-en-yl]-pregnane 
• 115527-12-3 (20R)-des-A,B-8β-(benzoyloxy)-23,24-dinorcholan-22-al 

Relevant articles and documents

2alpha-Methyl and 2beta-Methyl Analogs of 19,26-Dinor-1alpha,25-Dihydroxyvitamin D3 and Their Uses

This invention discloses 2α-methyl and 2β-methyl analogs of 19,26-dinor-1α,25-dihydroxyvitamin D3 and pharmaceutical uses therefor. These compounds exhibit in vitro biological activities evidencing use as an anti-cancer agent and for the treatm

2-METHYLENE-19,26-NOR-(20S)-1α-HYDROXYVITAMIN D3

Compounds of formula I are provided where X1 and X2 are independently selected from H or hydroxy protecting groups. Such compounds may be used in preparing pharmaceutical compositions and are useful in treating a variety of biologica

2-Methylene-19,26-Dinor-(20S,22E,25R)-Vitamin D Analogs

This invention discloses 2-methylene-19,26-dinor-(20S,22E,25R)-vitamin D analogs, and specifically 2-methylene-19,26-dinor-(20S,22E,25R)-1α,25-dihydroxyvitamin D3, and pharmaceutical uses therefor. This compound exhibits transcription activity